CORT CORCEPT THERAPEUTICS INC

NEUTRAL Impact: 3/10 Insider Cluster (4 insiders)
Horizon weeks Filed Jun 3, 2026 Processed 1d 20h ago
Insider cluster: 4 insiders, $5.5M total

Price Chart

Loading chart...

Executive Summary

Four CORT insiders — including the CEO, CFO, and two senior executives — sold a total of $5.50M in open-market shares within a one-week window. CFO Mokari Atabak led with a 40,000-share sale ($2.80M), while CEO Belanoff and executive Maduck each sold over $1M. Most sales followed option exercises and were concentrated at $69-70, near recent highs. The cluster dollar value is 0.07% of CORT's $7.6B market cap, which falls below the 0.1% threshold for materiality, and the selling pattern aligns with routine post-vesting diversification rather than a coordinated bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$5.5M
Insiders
4

Actionable Insight

This cluster is small relative to market cap and consistent with routine post-vesting diversification. No evidence of a coordinated bearish view. CORT continues to trade at $70 with 83% analyst bullish consensus. Monitor next earnings filing for business updates — insider selling at this scale is not actionable on its own.

Key Facts

  • 4 insiders sold $5.50M total in open-market sales over May 27 – June 1, 2026
  • CFO Atabak sold 40,000 shares for $2.80M (largest single sale)
  • CEO Belanoff sold 12,837 shares for $895K
  • Maduck sold 21,069 shares for $1.48M after exercising options
  • Total open-market sales = 0.07% of CORT's $7.6B market cap — below materiality threshold
  • Sales followed option exercises at $8.27-$19.26 strike prices, indicating routine profit-taking
  • CFO also had 395 shares withheld for taxes on June 2 (non-cash event)

Financial Impact

$5.50M in open-market sales, representing 0.07% of market cap

insider holdingsdilution

Risk Factors

  • Insider selling could accelerate if stock continues to rally toward all-time highs
  • Options exercises will add modest dilution (~78k shares exercised)
  • Large June 2026 gift of 300k shares by CEO Belanoff may precede additional sales (gift eliminates holding period for future sales)

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
83% bullish (12 analysts)

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-CORT-1780529647359
12 reports for CORT
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for CORT — sortable, filterable
Type Now
Jun 4, 2026
today
Insider Cluster
NEUTRAL ★ 3/10
awaiting T+1
Jun 3, 2026
1d ago
Insider Cluster
NEUTRAL ★ 3/10
awaiting T+1
Jun 3, 2026
1d ago
Insider Cluster
BEARISH ★ 5/10
awaiting T+1
Jun 3, 2026
1d ago
Insider Cluster
NEUTRAL ★ 4/10
awaiting T+1
Jun 3, 2026
2d ago
8-K
BULLISH ★ 6/10
$72.65 awaiting T+1awaiting T+1$72.96 (+0.42%)
Jun 2, 2026
2d ago
Insider Cluster
NEUTRAL ★ 3/10
$72.65 $74.89▲ +3.08%▲ +2.68%$72.96 (+0.42%)
May 29, 2026
6d ago
Insider Cluster
NEUTRAL ★ 3/10
$70.44 $71.20▲ +1.08%▲ +0.93%$72.96 (+3.57%)
May 29, 2026
6d ago
Insider Cluster
NEUTRAL ★ 3/10
awaiting T+1
May 1, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$51.42 $51.60▲ +0.35%▲ +0.69%$72.96 (+41.88%)
Mar 20, 2026
11w ago
Insider Cluster
NEUTRAL ★ 3/10
$34.64 $33.63▼ −2.92%▼ −4.02%$72.96 (+110.61%)
Showing 10 of 12

US Market Status

Market Open — Closes in 4m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access